在非手术瘤学中为多专业高级水平实践提供培训框架:通过开发和咨询到共识的旅程
M Clarkson1, R Khine2, F McDonald3
1Sheffield Hallam University, Sheffield, United Kingdom.
Radiography (London, England : 1995)
|December 15, 2024
概括
一个新的非手术瘤学 (NSO) 培训框架被开发出来,以解决劳动力短缺问题. 这一框架是根据现有课程进行调整的,旨在确保NSO学员获得公平和高标准的教育.
科学领域:
- 在瘤学瘤学.
- 医疗保健劳动力发展工作人员
- 医学教育 医学教育
背景情况:
- 非手术瘤学 (NSO) 部门面临着严重的劳动力短缺,预计到2028年,咨询瘤学家的缺口将达到21%.
- 现有的高级临床从业人员 (ACP) 和高级从业人员 (AP) 的培训缺乏标准化,这阻碍了他们弥合劳动力差距的潜力.
研究的目的:
- 开发并就标准化的NSO培训框架达成共识.
- 为NSO角色调整现有课程,确保与临床和教育需求保持一致.
- 确定实施新框架的潜在障碍.
主要方法:
- 使用了采用修改后的Delphi方法的多相设计.
- 在NSO医疗保健部门分发了一项在线调查,以收集专家意见.
- 该调查评估了新框架与既定课程相对应的适用性,并确定了实施挑战.
主要成果:
- 在框架与2017年多专业框架 (MPF) 保持一致方面,达成了高水平的共识 (90.2%).
- 介绍和实践能力 (CiP) 部分收到了积极的反 (98%的同意).
- 虽然总体上共识很强,但在专业特定能力和监督/评估清晰度方面发现了一些小的不一致性.
结论:
- 开发的NSO培训框架对于解决劳动力短缺和确保标准化,高质量的教育至关重要.
- 该框架促进了公平的培训途径,有可能改善劳动力保留和患者护理.
- 需要进一步精细化,以解决监督和评估中发现的不一致性.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338


